Trial site
Institutul de Urgenţă pentru Boli Cardiovasculare "Prof. Dr. C. C. Iliescu",
- 10running trials
- 5closed trials
The trials here
What the 15 trials at this site are about, from their registry records.
- Conditions
- High blood pressure7 trials
- Pulmonary arterial hypertension6 trials
- Atrial fibrillation3 trials
- Heart failure3 trials
- Stroke2 trials
- Amyloidosis1 trial
- Coronary artery disease1 trial
- Type 2 diabetes1 trial
- Phase
- Phase 313 trials
- Phase 21 trial
- Phase 41 trial
- Status
- Active, not recruiting5 trials
- Completed4 trials
- Recruiting4 trials
- Not yet recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Janssen Research & Development, LLC2 trials
- United Therapeutics2 trials
- Actelion1 trial
- Alnylam Pharmaceuticals1 trial
- AOP Orphan Pharmaceuticals AG1 trial
- and 8 more
Running trials
Recruiting
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
Recruiting
Active, not recruiting
Active, not recruiting
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
Enrolling by invitation
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- High blood pressure2 recruiting
- Amyloidosis1 recruiting
- Atrial fibrillation1 recruiting
- Heart failure1 recruiting
- Pulmonary arterial hypertension1 recruiting
- Stroke1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Completed
Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA)
Completed
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome
Completed
Terminated
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026